Literature DB >> 15979576

Interaction between integrin alpha(5) and fibronectin is required for metastasis of B16F10 melanoma cells.

Feng Qian1, Zi-Chao Zhang, Xue-Feng Wu, Yu-Pei Li, Qiang Xu.   

Abstract

In this study, we report the role of integrin alpha(5) in promoting melanoma metastasis. The alpha(5) expression was remarkably elevated in highly metastatic B16F10 melanoma cells compared to lowly metastatic B16F1 cells, whereas no significant changes were detected in those of integrin alpha(4), alpha(v), and beta(1) subunits. Neutralization of alpha(5) with anti-alpha(5) antibody significantly suppressed the potential of B16F10 cells for pulmonary metastasis in mice and inhibited cell adhesion or spreading to fibronectin in vitro. Furthermore, loss of the interaction between alpha(5) and fibronectin diminished cell survival and induced apoptosis in B16F10 cells. Above results provide clear evidence that integrin alpha(5) is positively correlated with melanoma metastasis and might be an anti-melanoma target.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15979576     DOI: 10.1016/j.bbrc.2005.06.039

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

1.  A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma.

Authors:  Kevin B Kim; Victor Prieto; Richard W Joseph; Abdul H Diwan; Gary E Gallick; Nicholas E Papadopoulos; Agop Y Bedikian; Luis H Camacho; Patrick Hwu; Chaan S Ng; Wei Wei; Marcella M Johnson; Sabine M Wittemer; Anna Vardeleon; Aaron Reckeweg; A Dimitrios Colevas
Journal:  Melanoma Res       Date:  2012-08       Impact factor: 3.599

Review 2.  Biomarkers for epithelial-mesenchymal transitions.

Authors:  Michael Zeisberg; Eric G Neilson
Journal:  J Clin Invest       Date:  2009-06-01       Impact factor: 14.808

3.  Antineoplastic effects of Rhodiola crenulata treatment on B16-F10 melanoma.

Authors:  Maxine C Dudek; Kaitlyn E Wong; Lotfi M Bassa; Maria Carmen Mora; Jennifer Ser-Dolansky; Jean M Henneberry; Giovanna M Crisi; Richard B Arenas; Sallie S Schneider
Journal:  Tumour Biol       Date:  2015-07-10

4.  Integrin α5β1 facilitates cancer cell invasion through enhanced contractile forces.

Authors:  Claudia Tanja Mierke; Benjamin Frey; Martina Fellner; Martin Herrmann; Ben Fabry
Journal:  J Cell Sci       Date:  2011-01-11       Impact factor: 5.285

Review 5.  Inflammation fuels tumor progress and metastasis.

Authors:  Jingyi Liu; Pengnian Charles Lin; Binhua P Zhou
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 6.  Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma.

Authors:  C S Scanlon; E A Van Tubergen; R C Inglehart; N J D'Silva
Journal:  J Dent Res       Date:  2012-11-05       Impact factor: 6.116

7.  Potentiation of tumor cell invasion by co-culture with monocytes accompanying enhanced production of matrix metalloproteinase and fibronectin.

Authors:  Go Kamoshida; Ayaka Matsuda; Risa Miura; Yuri Takashima; Arisa Katsura; Tsutomu Tsuji
Journal:  Clin Exp Metastasis       Date:  2012-09-29       Impact factor: 5.150

8.  Integrin α5 Suppresses the Phosphorylation of Epidermal Growth Factor Receptor and Its Cellular Signaling of Cell Proliferation via N-Glycosylation.

Authors:  Qinglei Hang; Tomoya Isaji; Sicong Hou; Sanghun Im; Tomohiko Fukuda; Jianguo Gu
Journal:  J Biol Chem       Date:  2015-10-19       Impact factor: 5.157

9.  Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative study.

Authors:  Alejandro D Ricart; Anthony W Tolcher; Glenn Liu; Kyle Holen; Garry Schwartz; Mark Albertini; Geoffrey Weiss; Salim Yazji; Chee Ng; George Wilding
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

10.  Role of the endothelium during tumor cell metastasis: is the endothelium a barrier or a promoter for cell invasion and metastasis?

Authors:  Claudia Tanja Mierke
Journal:  J Biophys       Date:  2009-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.